Metabolic network abnormalities in drug-naive Parkinson’s disease
Objective: The objective of this study is to identify and validate the metabolic PD-related pattern (PDRP) in de novo PD patients and to compare it…Relations of clinical symptoms with dopamine transporter imaging in untreated Parkinson’s disease
Objective: The aim of the present study was to determine the relations of clinical symptoms with nigrostriatal neuron loss in untreated patients with Parkinson's disease…Different patterns of brain activity during lower limb movements in Parkinson’s disease patients with and without freezing of gait
Objective: To assess brain functional MRI (fMRI) activity during a feet movement task in Parkinson’s disease patients with (PD-FoG) and without freezing of gait (PD-noFoG)…Functional connectivity within the cerebellum and brainstem in essential tremor patients– a tailored resting state fMRI approach
Objective: To better understand the pathophysiology of essential tremor (ET) by analysing brainstem and cerebellar neuronal circuitry activity with tailored fMRI resting state methods. Background:…Neuroimaging in Parkinson’s disease dementia: Connecting the dots
Objective: To identify the neural substrates of Parkinson’s disease dementia (PDD) and Parkinson’s disease with Mild Cognitive Impairment (PD-MCI) using a network mapping approach. Background:…Comparison of Current DBS Platforms in the United States
Objective: To compare and contrast the currently available deep brain stimulation (DBS) platforms in the United States, their technical features, capabilities and practicality of usage.…Dielectric Properties of a Blood Plasma Predict Motor Deficits in a 6-Hydroxydopamine-Induced Rat Model of Parkinson’s Disease
Objective: This study presents a novel method of predicting the behavioral pattern in male Sprague-Dawley rats with motor deficits impairment, based on the measurement of…Predicting the functional impact on the performance of daily activities in people with PD: a novel approach based on objective measures obtained by inertial sensors
Objective: To predict global motor disabilities using symptomatology assessed with inertial sensors, medication regimen, and cognitive deficits through: (1) a clustering method on performance metrics…Substantia Nigra (SN) Hyperechogenicity as seen in Transcranial Sonography (TCS) is a reliable disease progression marker from Stage I to Stage II in Early Onset Parkinson’s Disease (EOPD)
Objective: To test the hypothesis that SN hyperechogenicity seen in transcranial sonography (TCS) can be used as a reliable disease progression marker from stage I…Speech impairment as a marker of clinical changes in premanifest Huntington’s disease
Objective: Speech disturbances have been described in premanifest Huntington’s Disease (HD). Yet a recent systematic review and meta-analysis highlighted disagreement in the literature regarding the…
- « Previous Page
- 1
- …
- 188
- 189
- 190
- 191
- 192
- …
- 217
- Next Page »